Speaker

Adrian Ortiz

Executive Director, Process Research and Development, Eli Lilly & Co.

Adrian Ortiz, Executive Director, Process Research and Development at Eli Lilly & Co., spoke at 6th Applied Biocatalysis & Enzyme Engineering Summit (Boston, United States of America, 30 Sept – 1 Oct 2026) in the session “Roundtable: Overcoming IP Barriers to Enable Data Sharing & Accelerate Innovation in Biocatalysis”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

6th Applied Biocatalysis & Enzyme Engineering Summit
30 Sept – 1 Oct 2026Boston, United States of America
- PanelRoundtable: Overcoming IP Barriers to Enable Data Sharing & Accelerate Innovation in BiocatalysisWith Jason Tedrow
- PanelPanel: Embedding Biocatalysis Upstream, When Does It Add Value & How Do You Make It Stick?With Doug Millar, Jovan Livada, Chris Schneider

More speakers at 6th Applied Biocatalysis & Enzyme Engineering Summit

Carlos Acevedo-Rocha
Researcher, DTU BRIGHT The Novo Nordisk Foundation Biotechnology Research Institute, Novo Nordisk
Yannick Bomble
Distinguished Principal Scientist, National Renewable Energy Laboratory (NREL)
Kui Chan
Principal Scientist, Cyrus Biotechnology Inc.
Andrew Currin
Chief Scientific Officer & Co-Founder, Imperagen
Rudi Fasan
Chair of Chemistry, University of Texas at Dallas
Emily Greenhagen
Director, Microbial Process Operations, Merck & Co

See all 15 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Adrian Ortiz, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].